Acquisitions (Details Narrative) - USD ($) |
6 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 05, 2019 |
Jun. 02, 2018 |
Mar. 31, 2016 |
Jun. 30, 2019 |
Dec. 31, 2018 |
Jun. 02, 2019 |
|
| Fair value of assets acquired and liabilities assumed | $ 900,000 | |||||
| Fair value of intangible assets acquired | $ 259,443 | |||||
| Business combination consideration transferred | $ 5,000,000 | $ 300,000 | ||||
| Purchase Agreement [Member] | Mr Diamantis [Member] | ||||||
| Purchase price paid | $ 658,537 | |||||
| Total cost of acquisition | 908,537 | |||||
| Diligence, legal and other costs | $ 250,000 | |||||
| Non Compete Intangible [Member] | ||||||
| Fair value of intangible assets acquired | $ 245,363 | |||||
| Remaining amortization period | 2 years | |||||
| Impairment of intangible assets | $ 200,000 | |||||
| Jamestown Regional Medical Center [Member] | ||||||
| Purchase price paid | 635,096 | |||||
| Closing costs of acquisition | 35,735 | |||||
| Legal costs | 115,000 | |||||
| Fair value of assets acquired and liabilities assumed | 8,201,766 | |||||
| Fair value of intangible assets acquired | $ 504,806 |
| X | ||||||||||
- Definition Business acquisition diligence legal and other costs. No definition available.
|
| X | ||||||||||
- Definition Closing costs of acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|